Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the Hottest Small Cap Stocks to Buy Now. On November 11, Andy Hsieh from ...

Patients with CML, unlike patients with acute lymphoblastic leukemia, are likely to have a longer life expectancy with and ...

The FDA approves generic dasatinib tablets, enhancing access and affordability for treating chronic myeloid leukemia and ...

We recently published 10 Firms Shining Bright in a Bleeding Market. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the ...

Updated clinical development strategy based on positive data In the third quarter of 2025, Mendus shaped up its clinical development plans for the lead program vididencel in myeloid malignancies.The u ...

GSK Canada is pleased to announce that Ojjaara (momelotinib) will now be reimbursed by Régie de l’assurance maladie du Québec ...

Unprecedented Phase 1 CML efficacy data and potential best-in-disease profile of TERN-701 featured in ASH 2025 abstract Upcoming ASH oral presentation to feature expanded and updated dataset from ...

Terns Pharmaceuticals, Inc. ( ($TERN) ) has released its Q3 earnings. Here is a breakdown of the information Terns Pharmaceuticals, Inc. presented ...

Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001 ...

Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced the presentation of new data from 14 studies across ...

Tract Bio ("Tract"), a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced the official opening of its new laboratory in Charlotte, ...

This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...